AU2020373165A1 - Anti-mullerian hormone polypeptides - Google Patents

Info

Publication number

AU2020373165A1

AU2020373165A1 AU2020373165A AU2020373165A AU2020373165A1 AU 2020373165 A1 AU2020373165 A1 AU 2020373165A1 AU 2020373165 A AU2020373165 A AU 2020373165A AU 2020373165 A AU2020373165 A AU 2020373165A AU 2020373165 A1 AU2020373165 A1 AU 2020373165A1

Authority

AU

Australia

Prior art keywords

amh

seq

analogue

amino acid

sequence

Prior art date

2019-10-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 108010005853 Anti-Mullerian Hormone Proteins 0.000 title claims abstract description 382
• 102100030173 Muellerian-inhibiting factor Human genes 0.000 title claims abstract description 376
• 239000000868 anti-mullerian hormone Substances 0.000 title claims abstract description 360
• 108090000765 processed proteins & peptides Proteins 0.000 title claims description 131
• 102000004196 processed proteins & peptides Human genes 0.000 title claims description 125
• 229920001184 polypeptide Polymers 0.000 title claims description 120
• 125000000539 amino acid group Chemical group 0.000 claims abstract description 91
• 230000004048 modification Effects 0.000 claims abstract description 65
• 238000012986 modification Methods 0.000 claims abstract description 65
• 210000004027 cell Anatomy 0.000 claims description 92
• 239000000203 mixture Substances 0.000 claims description 81
• 239000013598 vector Substances 0.000 claims description 78
• 238000011282 treatment Methods 0.000 claims description 70
• 108090000623 proteins and genes Proteins 0.000 claims description 64
• 230000000694 effects Effects 0.000 claims description 61
• 238000000034 method Methods 0.000 claims description 61
• 206010028980 Neoplasm Diseases 0.000 claims description 57
• 235000001014 amino acid Nutrition 0.000 claims description 57
• 201000011510 cancer Diseases 0.000 claims description 55
• 102000004169 proteins and genes Human genes 0.000 claims description 55
• 239000002243 precursor Substances 0.000 claims description 54
• 235000018102 proteins Nutrition 0.000 claims description 52
• 230000002611 ovarian Effects 0.000 claims description 49
• 210000004899 c-terminal region Anatomy 0.000 claims description 48
• 102000040430 polynucleotide Human genes 0.000 claims description 44
• 108091033319 polynucleotide Proteins 0.000 claims description 44
• 239000002157 polynucleotide Substances 0.000 claims description 44
• 241000282414 Homo sapiens Species 0.000 claims description 42
• 150000001413 amino acids Chemical group 0.000 claims description 42
• 229940024606 amino acid Drugs 0.000 claims description 38
• 238000006467 substitution reaction Methods 0.000 claims description 32
• 210000001672 ovary Anatomy 0.000 claims description 27
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 26
• 210000004291 uterus Anatomy 0.000 claims description 18
• 239000003795 chemical substances by application Substances 0.000 claims description 17
• 229940127089 cytotoxic agent Drugs 0.000 claims description 17
• 238000000746 purification Methods 0.000 claims description 16
• 239000003814 drug Substances 0.000 claims description 15
• 239000002773 nucleotide Substances 0.000 claims description 15
• 125000003729 nucleotide group Chemical group 0.000 claims description 15
• 102000006437 Proprotein Convertases Human genes 0.000 claims description 14
• 108010044159 Proprotein Convertases Proteins 0.000 claims description 14
• 239000002254 cytotoxic agent Substances 0.000 claims description 13
• 230000007423 decrease Effects 0.000 claims description 13
• 238000004519 manufacturing process Methods 0.000 claims description 13
• 208000023275 Autoimmune disease Diseases 0.000 claims description 12
• 230000001225 therapeutic effect Effects 0.000 claims description 12
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 11
• 235000004279 alanine Nutrition 0.000 claims description 11
• 230000004927 fusion Effects 0.000 claims description 11
• 239000000710 homodimer Substances 0.000 claims description 11
• 208000017667 Chronic Disease Diseases 0.000 claims description 10
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 10
• 238000009169 immunotherapy Methods 0.000 claims description 10
• 239000004472 Lysine Substances 0.000 claims description 9
• 231100000599 cytotoxic agent Toxicity 0.000 claims description 7
• 241000283073 Equus caballus Species 0.000 claims description 6
• 241000282326 Felis catus Species 0.000 claims description 6
• 241001465754 Metazoa Species 0.000 claims description 6
• 238000001514 detection method Methods 0.000 claims description 6
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
• 229960000310 isoleucine Drugs 0.000 claims description 5
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
• 239000013607 AAV vector Substances 0.000 claims description 4
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
• 230000030833 cell death Effects 0.000 claims description 4
• 230000000973 chemotherapeutic effect Effects 0.000 claims description 4
• 210000002394 ovarian follicle Anatomy 0.000 claims description 4
• 239000004474 valine Substances 0.000 claims description 4
• 230000005779 cell damage Effects 0.000 claims description 3
• 208000037887 cell injury Diseases 0.000 claims description 3
• 230000001024 immunotherapeutic effect Effects 0.000 claims description 2
• 230000003439 radiotherapeutic effect Effects 0.000 claims description 2
• 102100025511 Anti-Muellerian hormone type-2 receptor Human genes 0.000 abstract description 29
• 101710089052 Anti-Muellerian hormone type-2 receptor Proteins 0.000 abstract description 28
• 239000000556 agonist Substances 0.000 abstract description 6
• 108010076504 Protein Sorting Signals Proteins 0.000 description 61
• 125000003275 alpha amino acid group Chemical group 0.000 description 38
• 101001011645 Homo sapiens Muellerian-inhibiting factor Proteins 0.000 description 35
• 238000003776 cleavage reaction Methods 0.000 description 31
• 230000014509 gene expression Effects 0.000 description 31
• 230000007017 scission Effects 0.000 description 31
• 238000012545 processing Methods 0.000 description 27
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 25
• 150000007523 nucleic acids Chemical class 0.000 description 25
• 150000001875 compounds Chemical class 0.000 description 21
• 230000035558 fertility Effects 0.000 description 21
• 108020004414 DNA Proteins 0.000 description 20
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
• 230000027455 binding Effects 0.000 description 18
• 102000039446 nucleic acids Human genes 0.000 description 18
• 108020004707 nucleic acids Proteins 0.000 description 18
• 102000005962 receptors Human genes 0.000 description 18
• 108020003175 receptors Proteins 0.000 description 18
• 239000013604 expression vector Substances 0.000 description 17
• 239000002299 complementary DNA Substances 0.000 description 16
• 230000002797 proteolythic effect Effects 0.000 description 15
• 239000012634 fragment Substances 0.000 description 14
• 230000035772 mutation Effects 0.000 description 14
• 239000013612 plasmid Substances 0.000 description 14
• 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 13
• 239000012528 membrane Substances 0.000 description 13
• 238000013459 approach Methods 0.000 description 12
• 102000009027 Albumins Human genes 0.000 description 11
• 108010088751 Albumins Proteins 0.000 description 11
• 101100075830 Caenorhabditis elegans mab-5 gene Proteins 0.000 description 11
• 239000005089 Luciferase Substances 0.000 description 11
• 239000003636 conditioned culture medium Substances 0.000 description 11
• 230000006870 function Effects 0.000 description 11
• 238000001727 in vivo Methods 0.000 description 11
• 230000028327 secretion Effects 0.000 description 11
• 238000002741 site-directed mutagenesis Methods 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 208000024891 symptom Diseases 0.000 description 11
• 108060001084 Luciferase Proteins 0.000 description 10
• 230000004913 activation Effects 0.000 description 10
• 238000002512 chemotherapy Methods 0.000 description 10
• 208000035475 disorder Diseases 0.000 description 10
• 238000005516 engineering process Methods 0.000 description 10
• 239000005556 hormone Substances 0.000 description 10
• 229940088597 hormone Drugs 0.000 description 10
• 238000000338 in vitro Methods 0.000 description 10
• 230000001965 increasing effect Effects 0.000 description 10
• 239000002609 medium Substances 0.000 description 10
• 210000001519 tissue Anatomy 0.000 description 10
• 238000001262 western blot Methods 0.000 description 10
• 201000010099 disease Diseases 0.000 description 9
• 239000003623 enhancer Substances 0.000 description 9
• 239000000463 material Substances 0.000 description 9
• 239000011347 resin Substances 0.000 description 9
• 229920005989 resin Polymers 0.000 description 9
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 8
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 8
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 8
• 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 8
• 101700032040 SMAD1 Proteins 0.000 description 8
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 238000007792 addition Methods 0.000 description 8
• 230000006378 damage Effects 0.000 description 8
• 238000009472 formulation Methods 0.000 description 8
• 208000000509 infertility Diseases 0.000 description 8
• 230000036512 infertility Effects 0.000 description 8
• 230000035935 pregnancy Effects 0.000 description 8
• 206010036601 premature menopause Diseases 0.000 description 8
• 238000004321 preservation Methods 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 229940124597 therapeutic agent Drugs 0.000 description 8
• 239000013603 viral vector Substances 0.000 description 8
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 7
• 239000003963 antioxidant agent Substances 0.000 description 7
• 235000006708 antioxidants Nutrition 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• -1 e.g. Proteins 0.000 description 7
• 239000000499 gel Substances 0.000 description 7
• 229920001223 polyethylene glycol Polymers 0.000 description 7
• 208000017942 premature ovarian failure 1 Diseases 0.000 description 7
• 230000011664 signaling Effects 0.000 description 7
• 230000035897 transcription Effects 0.000 description 7
• 238000013518 transcription Methods 0.000 description 7
• 241000701161 unidentified adenovirus Species 0.000 description 7
• 230000003612 virological effect Effects 0.000 description 7
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
• 101100313161 Caenorhabditis elegans mab-9 gene Proteins 0.000 description 6
• 241000282472 Canis lupus familiaris Species 0.000 description 6
• 201000009273 Endometriosis Diseases 0.000 description 6
• 241000588724 Escherichia coli Species 0.000 description 6
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 6
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 6
• 102000004961 Furin Human genes 0.000 description 6
• 108090001126 Furin Proteins 0.000 description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 description 6
• 239000002202 Polyethylene glycol Substances 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 239000002246 antineoplastic agent Substances 0.000 description 6
• 230000005784 autoimmunity Effects 0.000 description 6
• 238000010367 cloning Methods 0.000 description 6
• 229910017052 cobalt Inorganic materials 0.000 description 6
• 239000010941 cobalt Substances 0.000 description 6
• GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 6
• 229940028334 follicle stimulating hormone Drugs 0.000 description 6
• 210000002503 granulosa cell Anatomy 0.000 description 6
• 231100000535 infertility Toxicity 0.000 description 6
• 238000002347 injection Methods 0.000 description 6
• 239000007924 injection Substances 0.000 description 6
• 239000002502 liposome Substances 0.000 description 6
• 239000000178 monomer Substances 0.000 description 6
• 230000001323 posttranslational effect Effects 0.000 description 6
• 208000016685 primary ovarian failure Diseases 0.000 description 6
• 238000001959 radiotherapy Methods 0.000 description 6
• 230000007115 recruitment Effects 0.000 description 6
• 230000004044 response Effects 0.000 description 6
• 238000001356 surgical procedure Methods 0.000 description 6
• 238000001890 transfection Methods 0.000 description 6
• 241000702421 Dependoparvovirus Species 0.000 description 5
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 5
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
• 238000010521 absorption reaction Methods 0.000 description 5
• 239000004480 active ingredient Substances 0.000 description 5
• 230000002411 adverse Effects 0.000 description 5
• 108010083586 anti-Mullerian hormone receptor Proteins 0.000 description 5
• 210000004369 blood Anatomy 0.000 description 5
• 239000008280 blood Substances 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 239000003433 contraceptive agent Substances 0.000 description 5
• 239000000539 dimer Substances 0.000 description 5
• 239000012894 fetal calf serum Substances 0.000 description 5
• 238000001802 infusion Methods 0.000 description 5
• 238000003670 luciferase enzyme activity assay Methods 0.000 description 5
• 210000003101 oviduct Anatomy 0.000 description 5
• 239000008194 pharmaceutical composition Substances 0.000 description 5
• 229920002704 polyhistidine Polymers 0.000 description 5
• 229920000642 polymer Polymers 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
• 101000828537 Homo sapiens Synaptic functional regulator FMR1 Proteins 0.000 description 4
• 241000725303 Human immunodeficiency virus Species 0.000 description 4
• 101001011651 Mus musculus Muellerian-inhibiting factor Proteins 0.000 description 4
• 206010033128 Ovarian cancer Diseases 0.000 description 4
• 206010061535 Ovarian neoplasm Diseases 0.000 description 4
• 102000035195 Peptidases Human genes 0.000 description 4
• 108091005804 Peptidases Proteins 0.000 description 4
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
• 239000004365 Protease Substances 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• 102100023532 Synaptic functional regulator FMR1 Human genes 0.000 description 4
• 230000032683 aging Effects 0.000 description 4
• 238000002659 cell therapy Methods 0.000 description 4
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
• 230000002254 contraceptive effect Effects 0.000 description 4
• 238000013270 controlled release Methods 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 238000000502 dialysis Methods 0.000 description 4
• 230000003292 diminished effect Effects 0.000 description 4
• 239000002552 dosage form Substances 0.000 description 4
• 239000003937 drug carrier Substances 0.000 description 4
• 239000003995 emulsifying agent Substances 0.000 description 4
• 150000002148 esters Chemical class 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 239000007943 implant Substances 0.000 description 4
• 238000011534 incubation Methods 0.000 description 4
• 208000014674 injury Diseases 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 210000003292 kidney cell Anatomy 0.000 description 4
• 230000007774 longterm Effects 0.000 description 4
• 239000008363 phosphate buffer Substances 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 238000006366 phosphorylation reaction Methods 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 239000003755 preservative agent Substances 0.000 description 4
• 230000002265 prevention Effects 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 235000019419 proteases Nutrition 0.000 description 4
• 230000005855 radiation Effects 0.000 description 4
• 230000010076 replication Effects 0.000 description 4
• 239000000523 sample Substances 0.000 description 4
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
• 239000000829 suppository Substances 0.000 description 4
• 230000008685 targeting Effects 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 241000649044 Adeno-associated virus 9 Species 0.000 description 3
• 239000004475 Arginine Substances 0.000 description 3
• 241000282693 Cercopithecidae Species 0.000 description 3
• 108091035707 Consensus sequence Proteins 0.000 description 3
• KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 3
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
• 241000206602 Eukaryota Species 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 241000238631 Hexapoda Species 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• 108091006905 Human Serum Albumin Proteins 0.000 description 3
• 102000008100 Human Serum Albumin Human genes 0.000 description 3
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 3
• 108060003951 Immunoglobulin Proteins 0.000 description 3
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 108010071390 Serum Albumin Proteins 0.000 description 3
• 102000007562 Serum Albumin Human genes 0.000 description 3
• 241000700584 Simplexvirus Species 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 239000002671 adjuvant Substances 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 230000001580 bacterial effect Effects 0.000 description 3
• 239000012148 binding buffer Substances 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 230000000903 blocking effect Effects 0.000 description 3
• 229940098773 bovine serum albumin Drugs 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 239000012829 chemotherapy agent Substances 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 235000012343 cottonseed oil Nutrition 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 238000010494 dissociation reaction Methods 0.000 description 3
• 230000005593 dissociations Effects 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 238000010828 elution Methods 0.000 description 3
• 239000000839 emulsion Substances 0.000 description 3
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
• 210000003527 eukaryotic cell Anatomy 0.000 description 3
• 235000011187 glycerol Nutrition 0.000 description 3
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 3
• 102000018358 immunoglobulin Human genes 0.000 description 3
• 210000003734 kidney Anatomy 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 239000007788 liquid Substances 0.000 description 3
• 238000004020 luminiscence type Methods 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 230000009245 menopause Effects 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 229930182817 methionine Natural products 0.000 description 3
• 238000010172 mouse model Methods 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 239000003921 oil Substances 0.000 description 3
• 239000004006 olive oil Substances 0.000 description 3
• 238000011275 oncology therapy Methods 0.000 description 3
• 230000037361 pathway Effects 0.000 description 3
• 238000010647 peptide synthesis reaction Methods 0.000 description 3
• 230000026731 phosphorylation Effects 0.000 description 3
• 229920000136 polysorbate Polymers 0.000 description 3
• 230000002028 premature Effects 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 230000002035 prolonged effect Effects 0.000 description 3
• 230000005892 protein maturation Effects 0.000 description 3
• 230000006337 proteolytic cleavage Effects 0.000 description 3
• 230000002829 reductive effect Effects 0.000 description 3
• 230000001850 reproductive effect Effects 0.000 description 3
• 239000008159 sesame oil Substances 0.000 description 3
• 235000011803 sesame oil Nutrition 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 235000000346 sugar Nutrition 0.000 description 3
• 150000008163 sugars Chemical class 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 230000000699 topical effect Effects 0.000 description 3
• 230000005030 transcription termination Effects 0.000 description 3
• 230000001131 transforming effect Effects 0.000 description 3
• 239000003656 tris buffered saline Substances 0.000 description 3
• 210000001215 vagina Anatomy 0.000 description 3
• 239000000080 wetting agent Substances 0.000 description 3
• PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 2
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
• NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
• 108090000695 Cytokines Proteins 0.000 description 2
• 102000004127 Cytokines Human genes 0.000 description 2
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
• IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
• 150000008574 D-amino acids Chemical class 0.000 description 2
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• 241000255925 Diptera Species 0.000 description 2
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 239000004150 EU approved colour Substances 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 206010014733 Endometrial cancer Diseases 0.000 description 2
• 206010014759 Endometrial neoplasm Diseases 0.000 description 2
• LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
• 208000001640 Fibromyalgia Diseases 0.000 description 2
• BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
• 102100039556 Galectin-4 Human genes 0.000 description 2
• 208000007465 Giant cell arteritis Diseases 0.000 description 2
• 102000005731 Glucose-6-phosphate isomerase Human genes 0.000 description 2
• 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108010008488 Glycylglycine Proteins 0.000 description 2
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 2
• 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 241001138401 Kluyveromyces lactis Species 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• 150000008575 L-amino acids Chemical class 0.000 description 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 240000007472 Leucaena leucocephala Species 0.000 description 2
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
• 241001529936 Murinae Species 0.000 description 2
• 102000008300 Mutant Proteins Human genes 0.000 description 2
• 108010021466 Mutant Proteins Proteins 0.000 description 2
• SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 2
• 235000019483 Peanut oil Nutrition 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 108091000080 Phosphotransferase Proteins 0.000 description 2
• 229920002873 Polyethylenimine Polymers 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
• 201000004681 Psoriasis Diseases 0.000 description 2
• 241000700159 Rattus Species 0.000 description 2
• 101000930457 Rattus norvegicus Albumin Proteins 0.000 description 2
• 108020005091 Replication Origin Proteins 0.000 description 2
• 208000034189 Sclerosis Diseases 0.000 description 2
• 241000607720 Serratia Species 0.000 description 2
• DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
• 241000256251 Spodoptera frugiperda Species 0.000 description 2
• 108090000787 Subtilisin Proteins 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
• 208000026928 Turner syndrome Diseases 0.000 description 2
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
• 208000027418 Wounds and injury Diseases 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 230000001919 adrenal effect Effects 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 229940121375 antifungal agent Drugs 0.000 description 2
• 239000003429 antifungal agent Substances 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 235000009582 asparagine Nutrition 0.000 description 2
• 229960001230 asparagine Drugs 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 230000008901 benefit Effects 0.000 description 2
• SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
• 230000000975 bioactive effect Effects 0.000 description 2
• 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
• 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 210000003679 cervix uteri Anatomy 0.000 description 2
• 239000002738 chelating agent Substances 0.000 description 2
• 229960004926 chlorobutanol Drugs 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 229940110456 cocoa butter Drugs 0.000 description 2
• 235000019868 cocoa butter Nutrition 0.000 description 2
• 235000005687 corn oil Nutrition 0.000 description 2
• 239000002285 corn oil Substances 0.000 description 2
• 239000002385 cottonseed oil Substances 0.000 description 2
• 230000001351 cycling effect Effects 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 231100000517 death Toxicity 0.000 description 2
• 230000002939 deleterious effect Effects 0.000 description 2
• 238000012217 deletion Methods 0.000 description 2
• 230000037430 deletion Effects 0.000 description 2
• UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000002270 dispersing agent Substances 0.000 description 2
• 239000006185 dispersion Substances 0.000 description 2
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
• 210000004696 endometrium Anatomy 0.000 description 2
• 230000010502 episomal replication Effects 0.000 description 2
• 235000019441 ethanol Nutrition 0.000 description 2
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
• MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
• DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
• 210000004996 female reproductive system Anatomy 0.000 description 2
• 239000000796 flavoring agent Substances 0.000 description 2
• 230000004907 flux Effects 0.000 description 2
• 238000001415 gene therapy Methods 0.000 description 2
• 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 229940043257 glycylglycine Drugs 0.000 description 2
• 210000002149 gonad Anatomy 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 230000003054 hormonal effect Effects 0.000 description 2
• 150000002460 imidazoles Chemical class 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 239000003701 inert diluent Substances 0.000 description 2
• 208000021267 infertility disease Diseases 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• 239000007951 isotonicity adjuster Substances 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000008297 liquid dosage form Substances 0.000 description 2
• 210000005229 liver cell Anatomy 0.000 description 2
• 238000011866 long-term treatment Methods 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 230000002175 menstrual effect Effects 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 244000005700 microbiome Species 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 210000000318 mullerian duct Anatomy 0.000 description 2
• 201000006417 multiple sclerosis Diseases 0.000 description 2
• 238000007857 nested PCR Methods 0.000 description 2
• 235000019198 oils Nutrition 0.000 description 2
• 239000002674 ointment Substances 0.000 description 2
• 235000008390 olive oil Nutrition 0.000 description 2
• 210000000287 oocyte Anatomy 0.000 description 2
• 208000005963 oophoritis Diseases 0.000 description 2
• 230000003204 osmotic effect Effects 0.000 description 2
• 230000027758 ovulation cycle Effects 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000000312 peanut oil Substances 0.000 description 2
• 239000002304 perfume Substances 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 229960003742 phenol Drugs 0.000 description 2
• 102000020233 phosphotransferase Human genes 0.000 description 2
• 239000006187 pill Substances 0.000 description 2
• 210000002826 placenta Anatomy 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 230000012846 protein folding Effects 0.000 description 2
• 238000011127 radiochemotherapy Methods 0.000 description 2
• 238000011084 recovery Methods 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000005096 rolling process Methods 0.000 description 2
• 239000012146 running buffer Substances 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 210000002966 serum Anatomy 0.000 description 2
• 239000011780 sodium chloride Substances 0.000 description 2
• 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
• 235000010199 sorbic acid Nutrition 0.000 description 2
• 239000004334 sorbic acid Substances 0.000 description 2
• 229940075582 sorbic acid Drugs 0.000 description 2
• 235000010356 sorbitol Nutrition 0.000 description 2
• 239000000600 sorbitol Substances 0.000 description 2
• 239000003549 soybean oil Substances 0.000 description 2
• 235000012424 soybean oil Nutrition 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 230000010473 stable expression Effects 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 230000004083 survival effect Effects 0.000 description 2
• 239000000375 suspending agent Substances 0.000 description 2
• 238000013268 sustained release Methods 0.000 description 2
• 239000012730 sustained-release form Substances 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 206010043207 temporal arteritis Diseases 0.000 description 2
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
• 210000001685 thyroid gland Anatomy 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 235000010487 tragacanth Nutrition 0.000 description 2
• 239000000196 tragacanth Substances 0.000 description 2
• 229940116362 tragacanth Drugs 0.000 description 2
• 230000005026 transcription initiation Effects 0.000 description 2
• 230000010474 transient expression Effects 0.000 description 2
• 238000003146 transient transfection Methods 0.000 description 2
• 230000008733 trauma Effects 0.000 description 2
• 108010087967 type I signal peptidase Proteins 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 239000001993 wax Substances 0.000 description 2
• GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
• 229940058015 1,3-butylene glycol Drugs 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
• OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• JNODDICFTDYODH-UHFFFAOYSA-N 2-hydroxytetrahydrofuran Chemical compound OC1CCCO1 JNODDICFTDYODH-UHFFFAOYSA-N 0.000 description 1
• LAOROLNDGSJOEB-UHFFFAOYSA-N 3-(2-chlorophenothiazin-10-yl)-n,n-dimethylpropan-1-amine;4-(dimethylamino)-1,5-dimethyl-2-phenylpyrazol-3-one;n-(4-ethoxyphenyl)acetamide;1,3,7-trimethylpurine-2,6-dione Chemical compound CCOC1=CC=C(NC(C)=O)C=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1.C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 LAOROLNDGSJOEB-UHFFFAOYSA-N 0.000 description 1
• MZCACYLMMMXSKC-UHFFFAOYSA-N 32 amino acid peptide Chemical compound C=1C=CC=CC=1CC(C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCCNC(N)=N)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC(C)C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(NC(=O)C(NC(=O)C(CCC(O)=O)NC(=O)C(CCC(N)=O)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C1N(CCC1)C(=O)C1NCCC1)C(C)O)CC1=CC=CC=C1 MZCACYLMMMXSKC-UHFFFAOYSA-N 0.000 description 1
• HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 102100023990 60S ribosomal protein L17 Human genes 0.000 description 1
• 101710122462 65 kDa protein Proteins 0.000 description 1
• 206010000234 Abortion spontaneous Diseases 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 241000580270 Adeno-associated virus - 4 Species 0.000 description 1
• 241001164825 Adeno-associated virus - 8 Species 0.000 description 1
• 241000256118 Aedes aegypti Species 0.000 description 1
• 241000256173 Aedes albopictus Species 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 101710187573 Alcohol dehydrogenase 2 Proteins 0.000 description 1
• 101710133776 Alcohol dehydrogenase class-3 Proteins 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
• 208000003343 Antiphospholipid Syndrome Diseases 0.000 description 1
• 235000003276 Apios tuberosa Nutrition 0.000 description 1
• 208000032467 Aplastic anaemia Diseases 0.000 description 1
• 244000105624 Arachis hypogaea Species 0.000 description 1
• 235000010777 Arachis hypogaea Nutrition 0.000 description 1
• 235000010744 Arachis villosulicarpa Nutrition 0.000 description 1
• 241000282672 Ateles sp. Species 0.000 description 1
• 241001203868 Autographa californica Species 0.000 description 1
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 1
• 241000194108 Bacillus licheniformis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 208000023328 Basedow disease Diseases 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
• 241000255789 Bombyx mori Species 0.000 description 1
• 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 101800001415 Bri23 peptide Proteins 0.000 description 1
• 102100036850 C-C motif chemokine 23 Human genes 0.000 description 1
• 101800000655 C-terminal peptide Proteins 0.000 description 1
• 102400000107 C-terminal peptide Human genes 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 1
• 241000282552 Chlorocebus aethiops Species 0.000 description 1
• 206010008609 Cholangitis sclerosing Diseases 0.000 description 1
• 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
• 102000003780 Clusterin Human genes 0.000 description 1
• 108090000197 Clusterin Proteins 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 208000015943 Coeliac disease Diseases 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 208000011231 Crohn disease Diseases 0.000 description 1
• 241000701022 Cytomegalovirus Species 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 206010012438 Dermatitis atopic Diseases 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 241000255601 Drosophila melanogaster Species 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 241000588914 Enterobacter Species 0.000 description 1
• 241000588921 Enterobacteriaceae Species 0.000 description 1
• 241000588698 Erwinia Species 0.000 description 1
• 241000588722 Escherichia Species 0.000 description 1
• 241001522878 Escherichia coli B Species 0.000 description 1
• 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 description 1
• 239000001856 Ethyl cellulose Substances 0.000 description 1
• ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 208000000666 Fowlpox Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 206010070538 Gestational hypertension Diseases 0.000 description 1
• 108010021582 Glucokinase Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 208000024869 Goodpasture syndrome Diseases 0.000 description 1
• 208000015023 Graves' disease Diseases 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
• 201000005624 HELLP Syndrome Diseases 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
• 101710154606 Hemagglutinin Proteins 0.000 description 1
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
• 208000031220 Hemophilia Diseases 0.000 description 1
• 208000009292 Hemophilia A Diseases 0.000 description 1
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 1
• 206010019799 Hepatitis viral Diseases 0.000 description 1
• 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 1
• 102000005548 Hexokinase Human genes 0.000 description 1
• 102100029237 Hexokinase-4 Human genes 0.000 description 1
• 108700040460 Hexokinases Proteins 0.000 description 1
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
• 208000017604 Hodgkin disease Diseases 0.000 description 1
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 1
• 101100237760 Homo sapiens AMH gene Proteins 0.000 description 1
• 101100001532 Homo sapiens AMHR2 gene Proteins 0.000 description 1
• 101000713081 Homo sapiens C-C motif chemokine 23 Proteins 0.000 description 1
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 1
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 description 1
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 1
• 206010020850 Hyperthyroidism Diseases 0.000 description 1
• 101150047694 ID1 gene Proteins 0.000 description 1
• 206010021245 Idiopathic thrombocytopenic purpura Diseases 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 102000037982 Immune checkpoint proteins Human genes 0.000 description 1
• 108091008036 Immune checkpoint proteins Proteins 0.000 description 1
• 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
• 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 description 1
• 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102000004369 Insulin-like growth factor-binding protein 4 Human genes 0.000 description 1
• 108090000969 Insulin-like growth factor-binding protein 4 Proteins 0.000 description 1
• 101710096444 Killer toxin Proteins 0.000 description 1
• 241000588748 Klebsiella Species 0.000 description 1
• 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
• QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• 102000017578 LAG3 Human genes 0.000 description 1
• 241000713666 Lentivirus Species 0.000 description 1
• 102000009151 Luteinizing Hormone Human genes 0.000 description 1
• 108010073521 Luteinizing Hormone Proteins 0.000 description 1
• 241000282553 Macaca Species 0.000 description 1
• GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 101710089743 Mating factor alpha Proteins 0.000 description 1
• 206010027202 Meningitis bacterial Diseases 0.000 description 1
• 206010027260 Meningitis viral Diseases 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
• 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 1
• 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 1
• 102100030610 Mothers against decapentaplegic homolog 5 Human genes 0.000 description 1
• 101710143113 Mothers against decapentaplegic homolog 5 Proteins 0.000 description 1
• 230000025190 Mullerian duct regression Effects 0.000 description 1
• 108700005084 Multigene Family Proteins 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
• 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
• GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
• 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
• 208000005225 Opsoclonus-Myoclonus Syndrome Diseases 0.000 description 1
• 208000003435 Optic Neuritis Diseases 0.000 description 1
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 241000721454 Pemphigus Species 0.000 description 1
• 208000031845 Pernicious anaemia Diseases 0.000 description 1
• 102000001105 Phosphofructokinases Human genes 0.000 description 1
• 108010069341 Phosphofructokinases Proteins 0.000 description 1
• 102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
• 108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
• 241000709664 Picornaviridae Species 0.000 description 1
• 244000203593 Piper nigrum Species 0.000 description 1
• 206010035226 Plasma cell myeloma Diseases 0.000 description 1
• 206010036030 Polyarthritis Diseases 0.000 description 1
• 208000007048 Polymyalgia Rheumatica Diseases 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 208000005347 Pregnancy-Induced Hypertension Diseases 0.000 description 1
• 208000005107 Premature Birth Diseases 0.000 description 1
• 206010036590 Premature baby Diseases 0.000 description 1
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 1
• 101710176177 Protein A56 Proteins 0.000 description 1
• 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
• 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
• 241000588769 Proteus <enterobacteria> Species 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
• 102000013009 Pyruvate Kinase Human genes 0.000 description 1
• 108020005115 Pyruvate Kinase Proteins 0.000 description 1
• 108091030071 RNAI Proteins 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 208000012322 Raynaud phenomenon Diseases 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
• 208000033464 Reiter syndrome Diseases 0.000 description 1
• 241001068295 Replication defective viruses Species 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• 235000004443 Ricinus communis Nutrition 0.000 description 1
• 235000019485 Safflower oil Nutrition 0.000 description 1
• 241000607142 Salmonella Species 0.000 description 1
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
• 206010039710 Scleroderma Diseases 0.000 description 1
• 241000287219 Serinus canaria Species 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 208000021386 Sjogren Syndrome Diseases 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 108700011201 Streptococcus IgG Fc-binding Proteins 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 235000019486 Sunflower oil Nutrition 0.000 description 1
• UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 description 1
• 208000001106 Takayasu Arteritis Diseases 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 241000255588 Tephritidae Species 0.000 description 1
• 244000269722 Thea sinensis Species 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 239000007997 Tricine buffer Substances 0.000 description 1
• 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
• 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 244000000188 Vaccinium ovalifolium Species 0.000 description 1
• 206010047115 Vasculitis Diseases 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 description 1
• 240000008042 Zea mays Species 0.000 description 1
• 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
• 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 230000007488 abnormal function Effects 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 239000002253 acid Substances 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 208000002552 acute disseminated encephalomyelitis Diseases 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 201000009961 allergic asthma Diseases 0.000 description 1
• 208000026935 allergic disease Diseases 0.000 description 1
• 230000009285 allergic inflammation Effects 0.000 description 1
• 229940087168 alpha tocopherol Drugs 0.000 description 1
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
• WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 230000000259 anti-tumor effect Effects 0.000 description 1
• 239000000427 antigen Substances 0.000 description 1
• 102000036639 antigens Human genes 0.000 description 1
• 108091007433 antigens Proteins 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
• 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
• 235000010323 ascorbic acid Nutrition 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 239000011668 ascorbic acid Substances 0.000 description 1
• 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 201000008937 atopic dermatitis Diseases 0.000 description 1
• 229940090047 auto-injector Drugs 0.000 description 1
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
• 208000036923 autoimmune primary adrenal insufficiency Diseases 0.000 description 1
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
• 208000010928 autoimmune thyroid disease Diseases 0.000 description 1
• 201000009904 bacterial meningitis Diseases 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• 229960002903 benzyl benzoate Drugs 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 108091008324 binding proteins Proteins 0.000 description 1
• 238000004166 bioassay Methods 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 230000001851 biosynthetic effect Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 230000036760 body temperature Effects 0.000 description 1
• 108010006025 bovine growth hormone Proteins 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 235000019437 butane-1,3-diol Nutrition 0.000 description 1
• 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
• 210000004900 c-terminal fragment Anatomy 0.000 description 1
• 239000001768 carboxy methyl cellulose Substances 0.000 description 1
• 230000021523 carboxylation Effects 0.000 description 1
• 238000006473 carboxylation reaction Methods 0.000 description 1
• 239000004359 castor oil Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 208000019065 cervical carcinoma Diseases 0.000 description 1
• 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 238000004040 coloring Methods 0.000 description 1
• 230000001143 conditioned effect Effects 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 208000010247 contact dermatitis Diseases 0.000 description 1
• 229940124558 contraceptive agent Drugs 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 235000005822 corn Nutrition 0.000 description 1
• 239000008120 corn starch Substances 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 229960001305 cysteine hydrochloride Drugs 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 239000003145 cytotoxic factor Substances 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 230000003413 degradative effect Effects 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 238000000586 desensitisation Methods 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 235000014113 dietary fatty acids Nutrition 0.000 description 1
• KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
• 239000006196 drop Substances 0.000 description 1
• 235000013601 eggs Nutrition 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 239000012149 elution buffer Substances 0.000 description 1
• 230000032692 embryo implantation Effects 0.000 description 1
• 230000001804 emulsifying effect Effects 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 210000000981 epithelium Anatomy 0.000 description 1
• 229940093499 ethyl acetate Drugs 0.000 description 1
• 235000019325 ethyl cellulose Nutrition 0.000 description 1
• 229920001249 ethyl cellulose Polymers 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 238000013265 extended release Methods 0.000 description 1
• 206010016256 fatigue Diseases 0.000 description 1
• 229930195729 fatty acid Natural products 0.000 description 1
• 239000000194 fatty acid Substances 0.000 description 1
• 210000005002 female reproductive tract Anatomy 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 102000006482 fibulin Human genes 0.000 description 1
• 108010044392 fibulin Proteins 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 230000005021 gait Effects 0.000 description 1
• 229930182830 galactose Natural products 0.000 description 1
• 230000009368 gene silencing by RNA Effects 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 102000018146 globin Human genes 0.000 description 1
• 108060003196 globin Proteins 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229930195712 glutamate Natural products 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 150000002334 glycols Chemical class 0.000 description 1
• 230000002414 glycolytic effect Effects 0.000 description 1
• 210000002288 golgi apparatus Anatomy 0.000 description 1
• 231100000451 gonadotoxic Toxicity 0.000 description 1
• 230000003605 gonadotoxic effect Effects 0.000 description 1
• 230000001456 gonadotroph Effects 0.000 description 1
• 239000005090 green fluorescent protein Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 208000025750 heavy chain disease Diseases 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 208000003532 hypothyroidism Diseases 0.000 description 1
• 238000009802 hysterectomy Methods 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 238000001597 immobilized metal affinity chromatography Methods 0.000 description 1
• 230000014726 immortalization of host cell Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 229940102223 injectable solution Drugs 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000001361 intraarterial administration Methods 0.000 description 1
• 239000001573 invertase Substances 0.000 description 1
• 235000011073 invertase Nutrition 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 230000007794 irritation Effects 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 208000032839 leukemia Diseases 0.000 description 1
• 206010024627 liposarcoma Diseases 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 239000006210 lotion Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
• 210000005265 lung cell Anatomy 0.000 description 1
• 229940040129 luteinizing hormone Drugs 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
• 239000000347 magnesium hydroxide Substances 0.000 description 1
• 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 201000004792 malaria Diseases 0.000 description 1
• 210000005001 male reproductive tract Anatomy 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 210000001161 mammalian embryo Anatomy 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• 230000005906 menstruation Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 208000037819 metastatic cancer Diseases 0.000 description 1
• 208000011575 metastatic malignant neoplasm Diseases 0.000 description 1
• 239000004530 micro-emulsion Substances 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 208000015994 miscarriage Diseases 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
• 210000002161 motor neuron Anatomy 0.000 description 1
• 239000002324 mouth wash Substances 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 230000003387 muscular Effects 0.000 description 1
• 239000003471 mutagenic agent Substances 0.000 description 1
• 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
• 206010028417 myasthenia gravis Diseases 0.000 description 1
• 208000001611 myxosarcoma Diseases 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 239000012457 nonaqueous media Substances 0.000 description 1
• 239000002687 nonaqueous vehicle Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 238000007899 nucleic acid hybridization Methods 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 239000002751 oligonucleotide probe Substances 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 230000000771 oncological effect Effects 0.000 description 1
• 238000009806 oophorectomy Methods 0.000 description 1
• 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
• 210000000056 organ Anatomy 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 239000006072 paste Substances 0.000 description 1
• 235000010603 pastilles Nutrition 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 150000002978 peroxides Chemical class 0.000 description 1
• 201000008608 persistent Mullerian duct syndrome Diseases 0.000 description 1
• WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
• 101150009573 phoA gene Proteins 0.000 description 1
• 235000011007 phosphoric acid Nutrition 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 208000030428 polyarticular arthritis Diseases 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 230000004481 post-translational protein modification Effects 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 230000036515 potency Effects 0.000 description 1
• 201000011461 pre-eclampsia Diseases 0.000 description 1
• 208000036335 preeclampsia/eclampsia 1 Diseases 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 230000001902 propagating effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 239000000473 propyl gallate Substances 0.000 description 1
• 235000010388 propyl gallate Nutrition 0.000 description 1
• 229940075579 propyl gallate Drugs 0.000 description 1
• 229960004063 propylene glycol Drugs 0.000 description 1
• 235000013772 propylene glycol Nutrition 0.000 description 1
• 230000004952 protein activity Effects 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000009430 psychological distress Effects 0.000 description 1
• 239000013014 purified material Substances 0.000 description 1
• IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
• 150000003254 radicals Chemical class 0.000 description 1
• 208000002574 reactive arthritis Diseases 0.000 description 1
• 238000010188 recombinant method Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000009933 reproductive health Effects 0.000 description 1
• 210000004994 reproductive system Anatomy 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 235000005713 safflower oil Nutrition 0.000 description 1
• 239000003813 safflower oil Substances 0.000 description 1
• YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
• 229960001860 salicylate Drugs 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 208000010157 sclerosing cholangitis Diseases 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 238000002864 sequence alignment Methods 0.000 description 1
• 210000000717 sertoli cell Anatomy 0.000 description 1
• 239000004017 serum-free culture medium Substances 0.000 description 1
• 238000009097 single-agent therapy Methods 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
• 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
• 229940100996 sodium bisulfate Drugs 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• CSMWJXBSXGUPGY-UHFFFAOYSA-L sodium dithionate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)S([O-])(=O)=O CSMWJXBSXGUPGY-UHFFFAOYSA-L 0.000 description 1
• 235000010265 sodium sulphite Nutrition 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000011537 solubilization buffer Substances 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 208000000995 spontaneous abortion Diseases 0.000 description 1
• 239000007921 spray Substances 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000008223 sterile water Substances 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 230000004936 stimulating effect Effects 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 239000002600 sunflower oil Substances 0.000 description 1
• 230000001629 suppression Effects 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 238000004114 suspension culture Methods 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 238000002626 targeted therapy Methods 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 108010052178 teleocalcin Proteins 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 231100001274 therapeutic index Toxicity 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 230000034005 thiol-disulfide exchange Effects 0.000 description 1
• 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 229940113082 thymine Drugs 0.000 description 1
• 206010043778 thyroiditis Diseases 0.000 description 1
• 229960000984 tocofersolan Drugs 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 238000002604 ultrasonography Methods 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 210000003934 vacuole Anatomy 0.000 description 1
• 239000006213 vaginal ring Substances 0.000 description 1
• 229940044953 vaginal ring Drugs 0.000 description 1
• 239000000003 vaginal tablet Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 201000001862 viral hepatitis Diseases 0.000 description 1
• 201000010044 viral meningitis Diseases 0.000 description 1
• 210000003905 vulva Anatomy 0.000 description 1
• 210000000707 wrist Anatomy 0.000 description 1
• 239000002076 α-tocopherol Substances 0.000 description 1
• 235000004835 α-tocopherol Nutrition 0.000 description 1